Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
about
Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and preventionNew Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesDiagnostic and therapeutic biomarkers in pancreaticobiliary malignancyMicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancerBlood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.Downregulation of microRNA-30d promotes cell proliferation and invasion by targeting LRH-1 in colorectal carcinoma.miR-125b is associated with renal cell carcinoma cell migration, invasion and apoptosis.Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer.A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomasMicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancerExosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers.Increased MACC1 levels in tissues and blood identify colon adenoma patients at high risk.Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer.A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.A panel of microRNA signature in serum for colorectal cancer diagnosis.MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.Synergistic efficacy of Cullin1 and MMP-2 expressions in diagnosis and prognosis of colorectal cancer.mRNA-miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation.MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1.Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers.Effective targeting of colorectal cancer cells using TORC1/2 kinase inhibitors in vitro and in vivo.Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancerCircular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer.Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive miR-342 in Human Colorectal Cancer.Systematic literature review and clinical validation of circulating microRNAs as diagnostic biomarkers for colorectal cancerSerum miR-143 levels predict the pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells.Methods and novel technology for microRNA quantification in colorectal cancer screening.Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer.Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.NARRMDA: negative-aware and rating-based recommendation algorithm for miRNA-disease association prediction.Development of a predictive miRNA signature for breast cancer risk among high-risk women.Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.Role of Exosomal MicroRNAs and myomiRs in the Development of Cancer Cachexia-Associated Muscle Wasting.Human salivary microRNAs in Cancer.Applications of Extracellular RNAs in Oncology.
P2860
Q26742027-9E5655ED-4473-448D-B8C7-C80028F8B90EQ26748881-86D93451-DED2-4845-98C6-0CE0179C5574Q26767120-75A91DE8-D7AD-4F08-982F-9711A8D390E7Q26777313-6D293730-467E-4B6B-9ACE-9E21A3782CEAQ30238638-7D09E68D-6695-465E-85E9-EC63086CA2D2Q33674909-26CC97C7-67EC-45E2-B0E6-1AD76928209EQ33751241-6FD3F31D-E651-4B5F-8EF8-851E3E0DC500Q35993546-472CD7F8-0208-43FB-9EAD-1EBA73B4405CQ36091092-02854DB5-2AFD-48AC-91FE-5D99E4C1BACCQ36738904-DF4FE9F4-852E-4A54-9B0F-ED17CC5796D7Q37073022-6BBAE051-8C15-4E07-A86F-FE4515065D15Q37113292-86F1289E-C2EB-4350-85D2-798D1103570DQ37392819-ED43FBA8-C2F9-4303-BF5A-057C4095361AQ37529831-0CBF32C5-0800-4A9B-B4AB-0FE3F2DC2E2BQ37665639-E262A337-F463-4DD7-B4FF-5CA85786A65CQ37725573-F287DD4C-4C39-4031-89E6-497725B89222Q38291096-90627518-394F-4DF9-92B0-0A018AD20AB7Q38375695-4B08A586-D331-45C6-8850-85AF2DE49DDAQ38598443-022F61D5-6EA4-4C67-AE7E-A8BB0002B811Q38737087-9A0BFB6A-2B2B-43AB-B9D4-5CF807D3B58BQ38763590-D04FA683-5CEB-44E8-8C72-E915541CE154Q38802672-49630CEB-67E2-4FCF-8D42-106E72EC25EDQ38826546-53129098-3201-402D-AAAB-04ABD9BC6AD7Q38916573-592F7015-737F-448F-BAED-1E8A2CFF0D39Q38973406-8F12FB98-E840-43D2-8E83-622A76CBB7A2Q40258574-6237F2CF-84B4-40A1-A443-C9C3050BCC15Q40439857-59CA798A-F980-489C-BB00-836D1070AA8CQ41637392-D339536B-26B3-43F7-BB7D-678440BF3FD9Q42157952-D6046F47-AFCD-4196-9F98-2094C65AE16AQ43054579-E61D4074-76A4-40B7-B53B-D0C9B0560375Q43837554-96364A86-476C-448C-88F7-372267DC95C1Q44385577-AF56D6FF-502C-44AC-99D6-A55D39EA0877Q45065382-DC90D993-7C3E-46C9-9BE3-C60AAC276F20Q47372880-D2A24A5E-658B-455B-8579-328915A12041Q47426585-41B16353-9A7A-4E37-A57E-6B61A8DA8D24Q47724615-37B504C0-9967-4195-ADCF-4CE7825A33D3Q48171719-C354A619-479D-4EA2-B544-BBE71AE9D9F7Q49345061-9AC09E33-0FBA-416B-A3AF-59CC4E9A0B23Q52647687-424FAE54-39CA-4BC6-A96D-D7D27F8C0EBDQ52846340-2D172663-E03F-49CF-B335-FC76A8E36134
P2860
Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Serum miR-21, miR-29a, and miR ...... ection of Colorectal Neoplasia
@ast
Serum miR-21, miR-29a, and miR ...... ection of Colorectal Neoplasia
@en
type
label
Serum miR-21, miR-29a, and miR ...... ection of Colorectal Neoplasia
@ast
Serum miR-21, miR-29a, and miR ...... ection of Colorectal Neoplasia
@en
prefLabel
Serum miR-21, miR-29a, and miR ...... ection of Colorectal Neoplasia
@ast
Serum miR-21, miR-29a, and miR ...... ection of Colorectal Neoplasia
@en
P2093
P2860
P50
P1476
Serum miR-21, miR-29a, and miR ...... ection of Colorectal Neoplasia
@en
P2093
Atsushi Nakajima
Atsushi Yamada
C Richard Boland
Hajime Honjo
Hiroshi Ida
Makato Yagi
Manabu Muto
Naoshi Nishida
Norio Yukawa
Tadayuki Kou
P2860
P304
P356
10.1158/1078-0432.CCR-14-2793
P407
P577
2015-06-02T00:00:00Z